Sanuwave Health announces special meeting to vote on business combination

SANUWAVE Health announced the Company is holding a special meeting of stockholders on February 21, 2024 at 10:00 a.m. CT to vote on the previously announced merger with SEP Acquisition Corp. SANUWAVE announced on August 23, 2023 that the Company entered into an Agreement and Plan of Merger with Sweat Equity Partners and Mercury Life Sciences-affiliated SEPA. Upon closing, the combined company is expected to trade on the Nasdaq Capital Market under the symbol “SNWV“. The Company has commenced mailing proxy materials to stockholders to vote on proposals related to the merger with SEPA. Stockholders of record at the close of business on January 10, 2023 will be entitled to vote at the special meeting. The Company’s board of directors unanimously recommends that stockholders vote “FOR” the merger proposal.